|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/4045 | (2006.01) |
| (11) | Patento numeris | 3030227 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14753182.6 |
| Europos patento paraiškos padavimo data | 2014-08-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-08 |
| (46) | Apibrėžties vertimo paskelbimo data | 2020-06-10 |
| (86) | Numeris | PCT/US2014/049940 |
| Data | 2014-08-06 |
| (87) | Numeris | WO 2015/021153 |
| Data | 2015-02-12 |
| (30) | Numeris | Data | Šalis |
| 201361863325 P | 2013-08-07 | US | |
| 201361913066 P | 2013-12-06 | US |
| (72) |
YELESWARAM, Krishnaswamy, US
PARIKH, Bhavnish, US
MODI, Dilip P., US
SHETH, Trupti, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prailginto atpalaidavimo JAK1 inhibitoriaus dozavimo formos |
| SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2024-08-05 | 11 | 289.00 EUR |
| 2025-08-06 |